Bioventures Opportunities G. Yk Sells 1,343,801 Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Stock

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) major shareholder Bioventures Opportunities G. Yk sold 1,343,801 shares of the stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $0.08, for a total transaction of $107,504.08. Following the completion of the sale, the insider now directly owns 17,618,618 shares of the company’s stock, valued at $1,409,489.44. This trade represents a 7.09 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

CERo Therapeutics Price Performance

Shares of CERO stock traded down $0.01 on Friday, hitting $0.06. The stock had a trading volume of 31,185,395 shares, compared to its average volume of 20,494,506. CERo Therapeutics Holdings, Inc. has a 52-week low of $0.06 and a 52-week high of $12.80. The stock’s 50 day moving average is $0.13 and its 200-day moving average is $0.22.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.